Skip to main content

Table 1 Participant characteristics

From: Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group

# survey participants

Orthopaedic surgeon leadership group

Orthopaedic surgeons (AAOS outcomes SIG/ORS group)

N = 18

N = 69

% malea

100%

78%

Age categorya

 18–24

0%

0%

 25–34

0%

1%

 35–44

0%

17%

 45–54

33%

17%

 55–64

67%

41%

 65–74

0%

19%

 ≥75

0%

4%

Backgroundb

 Arthroplasty surgeon, private practice

56%

18%

 Arthroplasty surgeon, academic practice

39%

43%

 Arthroplasty researcher

11%

49%

 Orthopaedic surgeon, not focused on arthroplasty, private practice

11%

8%

Orthopaedic surgeon, not focused on arthroplasty, academic practice

17%

7%

 Patient

0%

7%

 Policy maker

0%

3%

Time spent planning/conducting arthroplasty trials

 0–10%

67%

57%

 11–20%

28%

16%

 21–30%

0%

16%

 31–50%

0%

4%

 >50%

6%

6%

Years practicing/doing research in arthroplasty

 < 5

6%

4%

 5–<10

0%

13%

 10–20

18%

23%

 >20

77%

59%

  1. aMissing values for AAOS-Outcome SIG and OMERACT cohorts: sex: 5 vs. none; age, 4 vs. none; bBackground, people could choose more than one option